Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.
Kieburtz
Karl
K
University of Rochester Medical Center, Rochester, New York 14620, USA. karl.kieburtz@ctcc.rochester.edu